---
figid: PMC5045229__ott-9-5825Fig4
figtitle: Cabozantinib provides dual inhibition of MET and VEGFR2 preventing the MET
  pathway from acting as an alternative pathway in the development of VEGF TKI resistance
organisms:
- Homo sapiens
- Mus musculus
- Diaporthe sclerotioides
- Calloplesiops altivelis
- Neotragus moschatus
pmcid: PMC5045229
filename: ott-9-5825Fig4.jpg
figlink: /pmc/articles/PMC5045229/figure/f4-ott-9-5825/
number: F4
caption: Cabozantinib provides dual inhibition of MET and VEGFR2 preventing the MET
  pathway from acting as an alternative pathway in the development of VEGF TKI resistance.
papertitle: 'Clinical use of cabozantinib in the treatment of advanced kidney cancer:
  efficacy, safety, and patient selection.'
reftext: Steven S Yu, et al. Onco Targets Ther. 2016;9:5825-5837.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9487467
figid_alias: PMC5045229__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5045229__F4
ndex: cc73d18f-dec4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5045229__ott-9-5825Fig4.html
  '@type': Dataset
  description: Cabozantinib provides dual inhibition of MET and VEGFR2 preventing
    the MET pathway from acting as an alternative pathway in the development of VEGF
    TKI resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hgf
  - Met
  - Vegfa
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Nfkb1
  - Zhx2
  - Akt1
  - Mdk
  - Mtor
  - Mdm2
  - Ephb2
  - Mapk1
  - Bad
  - HGF
  - IL6
  - SOS1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - FLT1
  - FLT4
  - KRAS
  - HRAS
  - NRAS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - MDM2
  - EPHB2
  - BAD
  - Cabozantinib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
